SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001593968-20-001744
Filing Date
2020-08-13
Accepted
2020-08-13 17:15:47
Documents
2
Period of Report
2020-08-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 3  
1 PRIMARY DOCUMENT primary_01.xml 3 1570
2 EX-24 DOCUMENT poa_millerrich2020.txt EX-24 4242
  Complete submission text file 0001593968-20-001744.txt   7271
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Issuer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, 37TH FL NEW YORK NY 10001
Business Address
Miller-Rich Nancy (Reporting) CIK: 0001735084 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37841 | Film No.: 201100243